...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
I hear you fouremm & very much appreciate your opinions but I don’t see how a naz listing could be any worse than this damn “expert market” garbage? Not sure how many more years a fella could be stuck here if nothings done naz or tsx wise? We could still be sitting here a few years from now waiting on that elusive deal??
 
If I look where the company/zen is at right now they should be ripe for BP - at least if zen did go public they haven’t had any failures in trials etc etc like rv & their in bed with heavy weights already - all things rv can’t really claim so if promoted right etc etc prior to a naz listing I’m not a 100% convinced it would be as ugly as you think. Definitely not as ugly as this expert market crap IMO. Maybe they can still bring in that rock star as you suggested at the bottom of your post or maybe the guy they brought in is that much more polished now???
"I would probably feel a little differently if Zenith had added someone to the board who has successfully created value in Biotech. Any average executive can get a public listing but it takes high quality business leadership and execution as well as quality science (which I think Zenith has) to create value through a public listing. JMO
 
I'd very much appreciate any feedback you may have on this....
Share
New Message
Please login to post a reply